CLINICAL_TRIALS
research
· 2025-10-01
Clinical Trial Update: A Study to Evaluate the MNV-201 in Patients With Low Risk MDS [Phase 1]
Summary
A Phase 1 clinical trial evaluating MNV-201 in patients with low-risk myelodysplastic syndromes, currently recruiting.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Minovia Therapeutics Ltd. | Conditions: Myelodysplastic Syndromes | Phase 1 | Status: RECRUITING